4.4 Review

Pathogenesis of Myocardial Ischemia-Reperfusion Injury and Rationale for Therapy

Journal

AMERICAN JOURNAL OF CARDIOLOGY
Volume 106, Issue 3, Pages 360-368

Publisher

EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjcard.2010.03.032

Keywords

-

Funding

  1. National Institutes of Health, Bethesda, Maryland [HL-075173, HL-080144, HL-090842]
  2. American Heart Association, Dallas, Texas [0640084N]
  3. American Diabetes Association, Alexandria, Virginia [7-08-MN-21-ADA]
  4. AHA-Jon Holden DeHaan Foundation, Naples, Florida [0970518N]
  5. Schering-Plough Corporation, Kenilworth, New Jersey

Ask authors/readers for more resources

Since the initial description of the phenomenon by Jennings et al 50 years ago, our understanding of the underlying mechanisms of reperfusion injury has grown significantly. Its pathogenesis reflects the confluence of multiple pathways, including ion channels, reactive oxygen species, inflammation, and endothelial dysfunction. The purposes of this review are to examine the current state of understanding of ischemia-reperfusion injury, as well as to highlight recent interventions aimed at this heretofore elusive target. In conclusion, despite its complexity our ongoing efforts to mitigate this form of injury should not be deterred, because nearly 2 million patients annually undergo either spontaneous (in the form of acute myocardial infarction) or iatrogenic (in the context of cardioplegic arrest) ischemia-reperfusion. (C) 2010 Elsevier Inc. All rights reserved. (Am J Cardiol 2010;106: 360-368)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available